Innovative ETFs Content Hub Biotech ETFs Strengthen as Amgen Invests in China’s BeiGene By Max ChenNovember 1, 2019
Innovative ETFs Content Hub Healthcare, Biotech ETFs XLV and XBI Slide on FDA’s Uncertain Outlook By Max ChenMarch 6, 2019
Innovative ETFs Content Hub Specialized Biotech ETF Rallies on MacroGenics Positive Trial Results By Max ChenFebruary 6, 2019
Equity ETFs Health Care ETFs Can Still Strengthen on Increased M&A Activity By Max ChenApril 28, 2016
Equity ETFs Silver Lining for Biotechnology ETFs After Pfizer Calls off Allergan Deal By Max ChenApril 6, 2016
